{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the protein DJ-1 are associated with a recessive form of early onset PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that DJ-1 mutations are associated with a recessive form of early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "SDS-PAGE gel of purified DJ-1 comparing L166P mutant with wild-type DJ-1.",
          "judgment": "No",
          "reasoning": "SDS-PAGE showing differences in protein migration does not directly model or reflect the disease pathogenesis/mechanism of Parkinson's disease. This is a very basic biochemical assay that shows structural differences but not functional impact relevant to the disease mechanism.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "The only functional evidence provided for the L166P variant is a basic SDS-PAGE comparison with wild-type DJ-1, which does not directly model or reflect the disease pathogenesis of Parkinson's disease. Therefore, PS3 cannot be applied according to ACMG guidelines."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the protein DJ-1 are associated with a recessive form of early onset PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that DJ-1 mutations are associated with a recessive form of early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No functional studies have been reported for these 'intermediate' mutations.",
          "judgment": "No",
          "reasoning": "The paper explicitly states that no functional studies have been reported for the M26I mutation.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "No functional studies have been reported for the M26I variant, so no functional evidence strength can be assigned according to ACMG guidelines."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "104"
        },
        "variant_string_id": "DJ-1 A104T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the protein DJ-1 are associated with a recessive form of early onset PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that DJ-1 mutations are associated with a recessive form of early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No functional studies have been reported for these 'intermediate' mutations.",
          "judgment": "No",
          "reasoning": "The paper explicitly states that no functional studies have been reported for the A104T mutation.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "No functional studies have been reported for the A104T variant, so no functional evidence strength can be assigned according to ACMG guidelines."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "D",
          "alt": "A",
          "position": "149"
        },
        "variant_string_id": "DJ-1 D149A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the protein DJ-1 are associated with a recessive form of early onset PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that DJ-1 mutations are associated with a recessive form of early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No functional studies have been reported for these 'intermediate' mutations.",
          "judgment": "No",
          "reasoning": "The paper explicitly states that no functional studies have been reported for the D149A mutation.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "No functional studies have been reported for the D149A variant, so no functional evidence strength can be assigned according to ACMG guidelines."
    }
  ]
}